What is Lifecore Biomedical, Inc.'s debt repayments?

Lifecore Biomedical, Inc. (LFCR) reported debt repayments of $36.4M in Q1 2026.

What is the long-term trend for Lifecore Biomedical, Inc.'s debt repayments?

Over 2 years (2022 to 2024), Lifecore Biomedical, Inc.'s debt repayments has grown at a -100.0% compound annual growth rate (CAGR), from $86.41M to $0.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Lifecore Biomedical, Inc. LFCR Debt Repayments

Debt Repayments at other companies

Baxter InternationalBAX

$0-100%

Thermo Fisher ScientificTMO

$1.41B+68.5%

Biodesix, Inc.BDSX

$5K-28.6%

Charles River LaboratoriesCRL

$355.68M+138%

Labcorp HoldingsLH

$0-100%

DanaherDHR

$1.43B—

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s debt repayments?: Lifecore Biomedical, Inc. (LFCR) reported debt repayments of $36.4M in Q1 2026.
What is the long-term trend for Lifecore Biomedical, Inc.'s debt repayments?: Over 2 years (2022 to 2024), Lifecore Biomedical, Inc.'s debt repayments has grown at a -100.0% compound annual growth rate (CAGR), from $86.41M to $0.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.